Seung Hyun Jung

Title: Innovations of Seung Hyun Jung

Introduction

Seung Hyun Jung is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds and their applications in cancer treatment. With a total of eight patents to his name, Jung's work exemplifies the intersection of chemistry and medicine.

Latest Patents

Among his latest patents, Jung has developed a novel heterotricyclic derivative compound that exhibits inhibitory activity against EZH1 and EZH2, which are crucial in cancer progression. This compound, along with its pharmaceutically acceptable salts, is disclosed for its potential use in treating tumors or cancer in subjects. Another significant patent involves a crystalline form of a salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide. This crystalline form is designed for easy incorporation into pharmaceutical compositions, enhancing its usability as an active ingredient.

Career Highlights

Seung Hyun Jung has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharm Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Jung has collaborated with notable colleagues such as Young Gil Ahn and Young Hee Jung. These partnerships have likely fostered a creative environment for the development of groundbreaking pharmaceutical solutions.

Conclusion

Seung Hyun Jung's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing cancer treatment. His work continues to inspire future research and development in the medical field.